YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

The US overweight and obese population will rise significantly in the next quarter century if current trends continue, and ...

Time spent sedentary beyond six hours per day during growth from childhood through young adulthood may cause an excess increase of 4 mmHg in systolic blood pressure, a new study shows.

PhRMA's “Middleman” and “Your Insurance” characters snatch savings away from a bewildered patient.

Miracle-Ear Foundation announces their Miracle Mission, which will provide the Gift of Sound™ to 100 Holocaust survivors with free hearing aids and related lifetime services on Monday, November 18 in ...

Singapore's competition regulator cleared South Korean conglomerate Hanwha Group's S$790.6 million ($589.30 million) takeover ...